[HTML][HTML] Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus
T Wen, C Jin, A Facciorusso, M Donadon… - … surgery and nutrition, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the sixth-most common cancer and the third leading
cause of cancer-related death in the world. However, 40–70% patients eventually suffer from …
cause of cancer-related death in the world. However, 40–70% patients eventually suffer from …
Recurrent hepatocellular carcinoma: Patterns, detection, staging and treatment
D Papaconstantinou, DI Tsilimigras… - Journal of …, 2022 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with the incidence of recurrence being as high as 88% even among patients who …
worldwide with the incidence of recurrence being as high as 88% even among patients who …
Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria
H Liu, ZG Wang, SY Fu, AJ Li, ZY Pan… - Journal of British …, 2016 - academic.oup.com
Background This study aimed to compare sequential treatment by transcatheter arterial
chemoembolization (TACE) and percutaneous radiofrequency ablation (RFA) with partial …
chemoembolization (TACE) and percutaneous radiofrequency ablation (RFA) with partial …
[HTML][HTML] Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation
HY Chen, SN Lu, CH Hung, JH Wang, CH Chen… - PLoS …, 2020 - journals.plos.org
Background Intrahepatic distant recurrence (IDR) is a significant problem for patients who
have undergone radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The …
have undergone radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The …
Open liver resection, laparoscopic liver resection, and percutaneous thermal ablation for patients with solitary small hepatocellular carcinoma (≤ 30 mm): review of …
L Viganò, A Laurenzi, L Solbiati, F Procopio… - Digestive surgery, 2018 - karger.com
Background: Patients with a single hepatocellular carcinoma (HCC)≤ 3 cm and preserved
liver function have the highest likelihood to be cured if treated. The most adequate treatment …
liver function have the highest likelihood to be cured if treated. The most adequate treatment …
Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases
R Matsuki, Y Mise, A Saiura, Y Inoue, T Ishizawa… - Surgery, 2016 - Elsevier
Background The feasibility of parenchymal-sparing hepatectomy has yet to be assessed
based on the tumor location, which affects the choice of treatment in patients with colorectal …
based on the tumor location, which affects the choice of treatment in patients with colorectal …
Oncologic superiority of anatomic resection of hepatocellular carcinoma by ultrasound-guided compression of the portal tributaries compared with nonanatomic …
Background The superiority of anatomic resection compared with nonanatomic resection for
hepatocellular carcinoma remains a matter of debate. Further, the technique for anatomic …
hepatocellular carcinoma remains a matter of debate. Further, the technique for anatomic …
Indocyanine green labeling of tumors in the liver recurring after radiofrequency ablation enables complete resection by fluorescence-guided surgery
Y Tashiro, T Aoki, T Hirai, T Koizumi… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Radiofrequency ablation (RFA) is used to treat primary and metastatic
tumors in the liver. However, local recurrence after RFA is frequent and subsequent salvage …
tumors in the liver. However, local recurrence after RFA is frequent and subsequent salvage …
Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy
S Yamagishi, Y Midorikawa, H Nakayama… - Hepatology …, 2019 - Wiley Online Library
Aim Although radiofrequency ablation (RFA) is an effective local treatment of hepatocellular
carcinoma (HCC), local recurrence is relatively frequent. We aimed to elucidate the validity …
carcinoma (HCC), local recurrence is relatively frequent. We aimed to elucidate the validity …
A single-center retrospective comparison of doxorubicin-loaded HepaSphere transarterial chemoembolization with conventional transarterial chemoembolization for …
F Kucukay, S Badem, A Karan, M Ozdemir… - Journal of Vascular and …, 2015 - Elsevier
Purpose To compare doxorubicin-loaded HepaSphere transarterial chemoembolization
versus conventional transarterial chemoembolization in terms of survival, time to recurrence …
versus conventional transarterial chemoembolization in terms of survival, time to recurrence …